Taro Inaba has over 20 years of experience in venture business within the healthcare sector. He is the founder of Remiges Ventures, an independent cross-border venture capital firm focused on life sciences, with principal offices in Seattle and Tokyo. Before establishing Remiges, Taro spent 13 years at Mitsui Ventures, where he pioneered a cross-border biotech investment model. His successful investments include Actimis Pharma, Boston Biomedical, and Hutchison Medipharma. Remiges Ventures plays a lead investor role in Series A rounds in North America, Europe, and Japan, and it creates de-novo companies based on intellectual properties from Japanese academia. Taro currently sits on the boards of seven Remiges portfolio companies. Additionally, he serves as Director of Koinobori, a philanthropic entity dedicated to drug discovery for mitochondrial diseases.

What I expect of LINK-J

"I expect LINK-J to become a hub where individuals from diverse backgrounds--including medical doctors, patients, academic researchers, entrepreneurs, investors, and other experts--can collaborate and exchange new ideas."

Message to LINK-J Special Members

"Let's work together to drive life science innovation!"